𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study

✍ Scribed by Jean-Claude Barbare; Olivier Bouché; Franck Bonnetain; Laetitia Dahan; Catherine Lombard-Bohas; Roger Faroux; Jean-Luc Raoul; Stéphane Cattan; Alain Lemoine; Jean-Frédéric Blanc; Jean-Pierre Bronowicki; Jean-Pierre Zarski; Sophie Cazorla; Dany Gargot; Thierry Thevenot; Emmanuel Diaz; Anne Bastie; Thomas Aparicio; Laurent Bedenne

Book ID
116429995
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
346 KB
Volume
45
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-acting octreotide versus placebo fo
Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study
✍ Gerhild Becker; Hans-Peter Allgaier; Manfred Olschewski; Andreas Zähringer; Hube 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

Although numerous treatment modalities have been explored in patients with advanced HCC, the therapeutic options are still limited. Somatostatin has been shown to have antimitotic activity in endocrine as well as in a variety of nonendocrine tumors. Expression of somatostatin receptors is found in H